No Data
No Data
Zhijiang Biology (688317.SH): has obtained the monkeypox product EU CE and UK MHRA certification.
On September 2, GeLongHui reported that ZhiJiang Biology (688317.SH) stated on the interactive platform that the company has obtained EU CE and United Kingdom MHRA certification for smallpox products, allowing sales in EU countries, the United Kingdom, and countries with relevant certifications. The company will continue to closely monitor the development of smallpox-related epidemics in overseas markets.
Zhijiang Biotech: 2024 Semi-Annual Report
Zhijiang Biotech: 2024 Semi-Annual Report Summary
Zhijiang Biology (688317.SH) released its semi-annual performance report, with a net income of 26.005 million yuan, a year-on-year decrease of 17.76%.
Zhi Jiang Biotech (688317.SH) has released its semi-annual report for 2024, reporting revenue of 9...
Zhijiang Biology (688317.SH): The net income for the first half of the year was 26.005 million yuan, a decrease of 17.76% compared to the same period last year.
Zhejiang Biotechnology (688317.SH) released its semi-annual report on August 28th. During the reporting period, the company achieved revenue of 94.5959 million yuan, a year-on-year decrease of 35.61%. The net income attributable to shareholders of the listed company was 26.005 million yuan, a year-on-year decrease of 17.76%. The net income attributable to the listed company after deducting non-recurring gains and losses was 23.5408 million yuan, a year-on-year decrease of 1.25%. A cash dividend of 1.1 yuan per 10 shares was distributed to all shareholders.
Zhejiang Medicine Co., Ltd. (688317.SH): Cumulative repurchase of 1.2% of shares, company completes buyback.
On August 19th, GeLongHui reported that BeyondSpring (688317.SH) had completed the repurchase of 2,314,287 shares, accounting for 1.20% of the total share capital of 192,157,999 shares on the day of disclosure. The highest repurchase price was 17.29 yuan/share and the lowest was 13.79 yuan/share, with an average repurchase price of 15.27 yuan/share. The total payment was RMB 35,331,332.71 (excluding transaction fees such as stamp duty and trading commission).
No Data
No Data